Drug Topics
FEBRUARY 28, 2025
With the disease burden remaining high, CVS Health announces new flu testing and treatment capabilities at approximately 1600 locations in selected states.
PharmaVoice
FEBRUARY 28, 2025
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 28, 2025
Exploring data from the past 20 years, researchers investigated the end-organ complications from alcohol in adolescents and young adults.
STAT
FEBRUARY 28, 2025
2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Explore groundbreaking innovations from top institutions and help crown the 2025 STAT Madness champion. Your vote determines who advances in this competition celebrating the best in biomedical research.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 28, 2025
Researchers compared hospitalization and mortality outcomes of older adults with and without restricted access to nirmatrelvir-ritonavir.
Fierce Healthcare
FEBRUARY 28, 2025
The HHS secretary said the public feedback mechanism is an obligation that imposes burden on the department. Not all types of rulemaking are exempt, and it remains to be seen just how much of the department's activity does or does not legally require public comment.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
FEBRUARY 28, 2025
In this episode, Jill Simonian and Codi Peterson explore the evolving role of pharmacists in medical cannabis, addressing legal complexities, patient counseling, and key considerations for safe and effective use.
Drug Topics
FEBRUARY 28, 2025
The expanded indication now includes patients aged 5 through 11 years in addition to those aged 12 through 65 years.
Pharmacy Times
FEBRUARY 28, 2025
Pharmacists play a crucial role in understanding and responding to these developments, ensuring patients remain informed about the latest advancements and potential threats.
Pharmaceutical Technology
FEBRUARY 28, 2025
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare diseases.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 28, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. It’s almost March! Which means voting for our annual STAT Madness competition starts Monday. I will see you in the brackets.
Pharmacy Times
FEBRUARY 28, 2025
If approved, gepotidacin (GSK) will be the first oral agent in 20 years to be FDA-approved for urinary tract infections (UTIs).
PQA
FEBRUARY 28, 2025
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a persons ability to access and use medications. As we work to address health equity and social determinants of health that affect medication use quality and patient outcomes, we believe that a diverse, equitable and inclusive workforce will strengthen PQAs efforts.
Pharmacy Times
FEBRUARY 28, 2025
The updated indication now includes pediatric patients aged 5 through 11 years.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 28, 2025
Last week at the ViVE conference in Nashville, two topics seemed to dominate most conversationsartificial intelligence and the impending snowstorm. (Music City got about two inches of snow.) | AI took the main stage at ViVE this month as discussions about adopting and scaling the technology have evolved significantly in just the past year.
pharmaphorum
FEBRUARY 28, 2025
Spain has agreed to reimburse Orchard Therapeutics' ex vivo gene therapy for the rare childhood disease metachromatic leukodystrophy.
Fierce Healthcare
FEBRUARY 28, 2025
Alignment Healthcare achieved its first year of positive adjusted EBITDA as a company, the insurer announced on release of its fourth-quarter earnings results. | Alignment Healthcare CEO John Kao continues to see strong performance in the company's future.
Pharmacy Times
FEBRUARY 28, 2025
RSV infection resulted in higher costs among specific age groups, especially patients aged 70 to 80 years.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
FEBRUARY 28, 2025
The collaboration will make it easier "for women to integrate personalized nutrition into their care and take charge of their health in a meaningful way, Nourish CEO Aidan Dewar said in a release.
pharmaphorum
FEBRUARY 28, 2025
Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology
Fierce Healthcare
FEBRUARY 28, 2025
Allegations of fraud, wasteful spending and policy violations occurring at the Executive Level were found to be substantiated by an independent government auditor. CEO Joseph Webb was hours away from a board vote on his contract renewal.
Pharmaceutical Technology
FEBRUARY 28, 2025
A survey has shown that pharma companies have low confidence their rare disease medicines can launch in the UK.
Fierce Healthcare
FEBRUARY 28, 2025
Clover Healths stock dipped Feb. 28 after the company announced an earnings per share loss of four cents and a 2% miss on quarterly revenue estimates, said Zacks Investment Research. | Clover Health's stock dipped further Friday even as the company projects to make at least $1.8 billion in revenue next year.
pharmaphorum
FEBRUARY 28, 2025
The FDA has approved loss of pulse detection for Google's Pixel Watch 3, almost six months after the smartwatch was launched in the US.
Fierce Healthcare
FEBRUARY 28, 2025
CHAI has signed on a slew of health systems and vendors that will support the initial launch of the product: Cleveland Clinic, Kaiser Permanente, Memorial Sloan Kettering, Mount Sinai Health System, Providence and Stanford Medicine, among others.
pharmaphorum
FEBRUARY 28, 2025
AbbVie's Rinvoq is poised to become the first oral targeted treatment for giant cell arteritis in the EU after being backed by the CHMP
Pharmaceutical Technology
FEBRUARY 28, 2025
The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for treating adults with giant cell arteritis (GCA).
Hospital Pharmacy Europe
FEBRUARY 28, 2025
The Government has made limited progress in achieving its vision of containing antimicrobial resistance (AMR), the National Audit Office (NAO) has warned. The public spending watchdog investigated how the Government is addressing AMR in light of it being a serous public health threat, after the Covid-19 pandemic showed that the UK was not as resilient to such threats as it expected to be.
Pharmaceutical Technology
FEBRUARY 28, 2025
With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are low.
PharmExec
FEBRUARY 28, 2025
Results from a Phase III study in pediatric patients demonstrated that Odactra reduced the total combined rhinitis score by 22% compared to placebo.
Pharmaceutical Technology
FEBRUARY 28, 2025
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell engagers (TCR-TCEs).
PharmExec
FEBRUARY 28, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
FEBRUARY 28, 2025
At the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium 2025, held on 13-15 February, final results from the randomised, multicentre, double-blind, Phase III COSMIC-313 clinical trial were presented.
Expert insights. Personalized for you.
311 
Let's personalize your content